Esophagus 2025

1 papers

Top Research Directions

The 4 research directions with Esophagus 2025 papers, ranked by paper count, next to 2024. Share is the fraction of the edition’s papers in the direction.

#Direction20252024Share 2025Share 20242024 rank
1Bridging the Causal Inference Gap in Retrospective Studies10100.0%0.0%—
2Finding Optimal Cutoffs for Continuous Biomarkers10100.0%0.0%—
3Objective Quantification of Physical Activity and Sleep Patterns10100.0%0.0%—
4Why Small Sample Single Center Studies Fail to Generalize10100.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Esophagus 2025 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare20242024 rank
1019tepx80 1100.0%14
2Kanazawa University 1100.0%0—
3Okayama University 1100.0%17

Download all institutions as CSV

About this data

Papers. Esophagus 2025 lists 1 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2024 use shares, since the edition went from 2 to 1 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 1 papers (100.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Esophagus 2025”, https://lacuna.tiptreesystems.com/venue/esophagus/2025.

Papers

Title
Association between accelerometer-measured light-intensity physical activity and tumor regression for male patients with esophageal cancer receiving neoadjuvant therapy: a retrospective cohort study